These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26746834)

  • 1. A large, benign prostatic cyst presented with an extremely high serum prostate-specific antigen level.
    Chen HK; Pemberton R
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26746834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum prostate-specific antigen and the biologic progression of prostate cancer.
    Kabalin JN; McNeal JE; Johnstone IM; Stamey TA
    Urology; 1995 Jul; 46(1):65-70. PubMed ID: 7541589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence of benign prostatic glandular tissue at surgical margins does not predict PSA recurrence.
    Kernek KM; Koch MO; Daggy JK; Juliar BE; Cheng L
    J Clin Pathol; 2005 Jul; 58(7):725-8. PubMed ID: 15976340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in prostate cancer at radical prostatectomy during the prostate specific antigen era: an Italian experience.
    Bollito E; Terrone C; Volpe A; Porpiglia F; Cracco C; Poggio M; Grande S; Righi L; Bellina M; Papotti M; Scarpa RM
    Anal Quant Cytol Histol; 2008 Jun; 30(3):152-9. PubMed ID: 18630840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of prostate cancer with cyst formation].
    Ishida K; Kubota Y; Takada T; Yamada T; Nakano M; Takahashi Y; Ishihara S; Deguchi T
    Hinyokika Kiyo; 2003 Apr; 49(4):235-7. PubMed ID: 12784721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens.
    Cheng L; Poulos CK; Pan CX; Jones TD; Daggy JK; Eble JN; Koch MO
    J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of minute (0.5 MM or less) focus of prostate adenocarcinoma on needle biopsy with radical prostatectomy specimen: role of prostate specific antigen density.
    Allan RW; Sanderson H; Epstein JI
    J Urol; 2003 Aug; 170(2 Pt 1):370-2. PubMed ID: 12853777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volume-based evaluation of serum assays for new prostate-specific antigen isoforms in the detection of prostate cancer.
    Naya Y; Fritsche HA; Bhadkamkar VA; Mikolajczyk SD; Rittenhouse HG; Babaian RJ
    Urology; 2004 Mar; 63(3):492-8. PubMed ID: 15028444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.
    Stamey TA; Johnstone IM; McNeal JE; Lu AY; Yemoto CM
    J Urol; 2002 Jan; 167(1):103-11. PubMed ID: 11743285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer.
    D'Amico AV; Wu Y; Chen MH; Nash M; Renshaw AA; Richie JP
    J Urol; 2001 Jan; 165(1):126-9. PubMed ID: 11125380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single small focus of prostate adenocarcinoma (< or = 1 mm and too small for grading) and clinical significant disease after radical prostatectomy.
    Taverna G; Colombo P; Seveso M; Giusti G; Piccinelli A; Benetti A; Graziotti P
    Arch Ital Urol Androl; 2006 Jun; 78(2):57-60. PubMed ID: 16929604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of potentially insignificant prostate cancer in men undergoing radical prostatectomy for clinically organ-confined disease.
    Miyake H; Sakai I; Harada K; Hara I; Eto H
    Int J Urol; 2005 Mar; 12(3):270-4. PubMed ID: 15828954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.
    Noguchi M; Stamey TA; McNeal JE; Yemoto CM
    J Urol; 2000 Nov; 164(5):1596-600. PubMed ID: 11025712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant hormonal therapy in stage C adenocarcinoma of the prostate.
    Andros EA; Danesghari F; Crawford ED
    Clin Invest Med; 1993 Dec; 16(6):510-5. PubMed ID: 7516835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do patients with low volume prostate cancer have prostate specific antigen recurrence following radical prostatectomy?
    Furusato B; Rosner IL; Osborn D; Ali A; Srivastava S; Davis CJ; Sesterhenn IA; McLeod DG
    J Clin Pathol; 2008 Sep; 61(9):1038-40. PubMed ID: 18552171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: a prospective multicenter clinical trial.
    Southwick PC; Catalona WJ; Partin AW; Slawin KM; Brawer MK; Flanigan RC; Patel A; Richie JP; Walsh PC; Scardino PT; Lange PH; Gasior GH; Parson RE; Loveland KG
    J Urol; 1999 Oct; 162(4):1346-51. PubMed ID: 10492194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of serum-free and total prostate-specific antigen due to prostatic intraepithelial neoplasia.
    Minardi D; Galosi AB; Dell'Atti L; Hanitzsch H; Mario P; Muzzonigro G
    Scand J Urol Nephrol; 2002; 36(5):323-9. PubMed ID: 12487735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The quotient of prostate-specific antigen and prostate volume. Improved differentiation between benign prostatic hyperplasia and locally circumscribed prostate cancer].
    Semjonow A; Hamm M; Rathert P
    Urologe A; 1993 May; 32(3):250-3. PubMed ID: 7685557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [PSA volume quotient: an additional parameter in diagnosis of locally confined prostate cancer].
    Gottfried HW; Kleinschmidt K; Flohr P; Miller K; Hautmann R
    Urologe A; 1993 Nov; 32(6):455-9. PubMed ID: 7506850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of Peripheral Vein Tumour Marker Levels, Internal Iliac Vein Tumour Marker Levels and Radical Prostatectomy Specimens in Patients with Prostate Cancer and Borderline High Prostate-Specific Antigen: A Pilot Study.
    Farrelly C; Lal P; Trerotola SO; Nadolski GJ; Watts MM; Gorrian CM; Guzzo TJ
    Cardiovasc Intervent Radiol; 2016 May; 39(5):724-731. PubMed ID: 26957011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.